Hormonal regulation of β-myosin heavy chain expression in the mouse left ventricle

Journal of Endocrinology

Volumn 216, Issue 3, 2013, Pages 287-296

  Patrizio, Mario ^a   Musumeci, Marco ^a   Piccone, Ambra ^a   Raggi, Carla ^a   Mattei, Elisabetta ^b   Marano, Giuseppe ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

Author keywords

adrenergic receptors; Myosin; Cardiac hypertrophy; Gender; Gene expression

Indexed keywords

MESSENGER RNA; METOPROLOL; MYOSIN HEAVY CHAIN BETA;

ANIMAL EXPERIMENT; AORTA COARCTATION; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HORMONAL REGULATION; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; CARDIOMEGALY; FEMALE; HEART VENTRICLES; HEMODYNAMICS; MALE; METOPROLOL; MICE; MYOSIN HEAVY CHAINS; OVARIECTOMY; RECEPTORS, ADRENERGIC, BETA; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 84875072973     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0201     Document Type: Article

References (45)

1. Agabiti-Rosei E & Muiesan ML 2002 Left ventricular hypertrophy and heart failure in women. Journal of Hypertension. Supplement 20 S34-S38.
2. Asai K, Yang GP, Geng YJ, Takagi G, Bishop S, Ishikawa Y, Shannon RP, Wagner TE, Vatner DE, Homcy CJ et al. 1999 β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(sα) mouse. Journal of Clinical Investigation 104 551-558. (doi:10.1172/JCI7418)
3. Baumhäkel M, Schlimmer N, Büyükafsar K, Arikan O & Böhm M 2008 Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice. Journal of Pharmacology and Experimental Therapeutics 325 818-823. (doi:10.1124/ jpet.107.135681)
4. Bernstein D, Fajardo G, Zhao M, Urashima T, Powers J, Berry G & Kobilka BK 2005 Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes. American Journal of Physiology. Heart and Circulation Physiology 289 H2441-H2449. (doi:10.1152/ajpheart.00005.2005)
5. 2+-ATPase and α-myosin heavy chain in rat hearts. Journal of Clinical Investigation 100 1742-1749. (doi:10.1172/ JCI119699)
6. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J et al. 2003 The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. European Heart Journal 24 442-463. (doi:10.1016/S0195-668X(02)00823-0)
7. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP & Lorell BH 1998 Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. Journal of the American College of Cardiology 32 1118-1125. (doi:10.1016/S0735-1097(98)00347-7)
8. Ecker PM, Lin CC, Powers J, Kobilka BK, Dubin AM & Bernstein D 2006 Effect of targeted deletions of β1- and β2-adrenergic-receptor subtypes on heart rate variability. American Journal of Physiology. Heart and Circulatory Physiology 290 H192-H199. (doi:10.1152/ajpheart. 00032.2005)
9. Fielitz J, Leuschner M, Zurbrügg HR, Hannack B, Pregla R, Hetzer R & Regitz-Zagrosek V 2004 Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. Journal of Molecular Medicine 82 809-820. (doi:10.1007/ s00109-004-0606-4)
10. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U et al. 2010 Female sex and estrogen receptor-β attenuate cardiac remodeling and apoptosis in pressure overload. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 298 1597-1606. (doi:10.1152/ajpregu. 00825.2009)
11. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, Gillijns H, Herijgers P, Flameng W, Carmeliet P et al. 2005 Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 112 1136-1144. (doi:10.1161/CIRCULATIONAHA.104.516963)
12. Hogg K, Swedberg K & McMurray J 2004 Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. Journal of the American College of Cardiology 43 317-332. (doi:10.1016/j.jacc.2003.07.046)
13. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B & Mahdavi V 1987 Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. Journal of Clinical Investigation 79 970-977. (doi:10.1172/JCI112908)
14. Izumo S, Nadal-Ginard B & Mahdavi V 1988 Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. PNAS 85 339-343. (doi:10.1073/pnas.85.2.339)
15. Kam KW, Qi JS, Chen M & Wong TM 2004 Estrogen reduces cardiac injury and expression of β1-adrenoceptor upon ischemic insult in the rat heart. Journal of Pharmacology and Experimental Therapeutics 309 8-15. (doi:10.1124/jpet.103.058339)
16. Krenz M & Robbins J 2004 Impact of β-myosin heavy chain expression on cardiac function during stress. Journal of the American College of Cardiology 44 2390-2397. (doi:10.1016/j.jacc.2004.09.044)
17. Krenz M, Sambe A, Bouyer-Dalloz F, Gulick J, Klevitsky R, Hewett TE, Osinka HE, Lorenz JN, Brosseau C, Federico A et al. 2003 Analysis of myosin heavy chain functionality in the heart. Journal of Biological Chemistry 278 17466-17474.
18. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2DDCT method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
19. López JE, Myagmar BE, Swigart PM, Montgomery MD, Haynam S, Bigos M, Rodrigo MC & Simpson PC 2011 β-Myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes. Circulation Research 109 629-638. (doi:10.1161/CIRCRESAHA. 111.243410)
20. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF et al. 1997 Changes in gene expression in the intact human heart. Downregulation of a-myosin heavy chain in hypertrophied, failing ventricular myocardium. Journal of Clinical Investigation 100 2315-2324. (doi:10.1172/JCI119770)
21. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD et al. 2002 Myocardial gene expression in dilated cardiomyopathy treated with β-blocking agents. New England Journal of Medicine 346 1357-1365. (doi:10.1056/NEJMoa012630)
22. 2+/calmodulin-dependent protein kinase II. British Journal of Pharmacology 157 705-715. (doi:10.1111/j. 1476-5381.2009.00212.x)
23. Modena MG, Muia N Jr, Avet P, Molinari R & Rossi R 1999 Effects of the transdermal 17β-estradiol on left ventricular anatomy and performance in hypertensive women. Hypertension 34 1041-1046. (doi:10.1161/01. HYP.34.5.1041)
24. Musumeci M, Maccari S, Sestili P, Signore M, Molinari P, Ambrosio C, Stati T, Colledge WH, Grace AA, Catalano L et al. 2011 Propranolol enhances cell cycle-related gene expression in pressure overloaded hearts. British Journal of Pharmacology 164 1917-1928. (doi:10.1111/ j.1476-5381.2011.01504.x)
25. O'Connell TD, Swigart PM, Rodrigo MC, Ishizaka S, Joho S, Turnbull L, Tecott LH, Baker AJ, Foster E, Grossman W et al. 2006 α1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload. Journal of Clinical Investigation 116 1005-1015. (doi:10.1172/JCI22811)
26. Patrizio M, Musumeci M, Stati T, Fasanaro P, Palazzesi S, Catalano L & Marano G 2007 Propranolol causes a paradoxical enhancement of cardiomyocyte fetal gene response to hypertrophic stimuli. British Journal of Pharmacology 152 216-222. (doi:10.1038/sj.bjp.0707350)
27. PatrizioM, Vago V, Musumeci M, Fecchi K, Sposi NM, Mattei E, Catalano L, Stati T & Marano G 2008 cAMP-mediated β-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes. Journal of Molecular and Cellular Cardiology 45 761-769. (doi:10.1016/j.yjmcc.2008.09.120)
28. Patten RD, Pourati I, Aronovitz MJ, Alsheikh-Ali A, Eder S, Force T, Mendelsohn ME & Karas RH 2008 17β-Estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. Journal of Cardiac Failure 14 245-253. (doi:10.1016/j.cardfail.2007.10.024)
29. Perlini S, Ferrero I, Palladini G, Tozzi R, Gatti C, Vezzoli M, Cesana F, Janetti MB, Clari F, Busca G et al. 2006 Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure. Hypertension 48 93-97. (doi:10.1161/01.HYP. 0000226859.42064.ea)
30. Pfeffer JM, Pfeffer MA, Fletcher P, Fishbein MC & Braunwald E 1982 Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. American Journal of Physiology 242 776-784.
31. Regitz-Zagrosek V, Brokat S & Tschope C 2007 Role of gender in heart failure with normal left ventricular ejection fraction. Progress in Cardiovascular Diseases 49 241-251. (doi:10.1016/j.pcad.2006.08.011)
32. Reiser PJ, Portman MA, Ning XH & Schomish Moravec C 2001 Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. American Journal of Physiology. Heart and Circulatory Physiology 280 H1814-H1820.
33. Rice R, Guinto P, Dowell-Martino C, He H, Hoyer K, Krenz M, Robbins J, Ingwall JS & Tardiff JC 2010 Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts. Journal of Molecular and Cellular Cardiology 48 979-988. (doi:10.1016/j.yjmcc.2009.11.018)
34. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr & Chien KR 1991 Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. PNAS 88 8277-8281. (doi:10.1073/pnas. 88.18.8277)
35. Rohrer DK, Desai KH, Jasper JR, Stevens ME, Regula DP Jr, Barsh GS, Bernstein D & Kobilka BK 1996 Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. PNAS 93 7375-7380. (doi:10.1073/pnas.93.14.7375)
36. de Simone G, Devereux RB, Daniels SR & Meyer RA 1995 Gender differences in left ventricular growth. Hypertension 26 979-983. (doi:10.1161/01. HYP.26.6.979)
37. Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, Mao L, Rockman HA, Korach KS & Murphy E 2005 Estrogen receptor-b mediates male-female differences in the development of pressure overload hypertrophy. American Journal of Physiology. Heart and Circulatory Physiology 288 H469-H476. (doi:10.1152/ajpheart. 00723.2004)
38. Takeo S, Elmoselhi AB, Goel R, Sentex E, Wang J & Dhalla NS 2000 Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil. Molecular and Cellular Biochemistry 213 111-118. (doi:10.1023/A:1007120332587)
39. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J & Leinwand LA 2000 Expression of the β (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. American Journal of Physiology. Heart and Circulatory Physiology 278 H412-H419.
40. Thawornkaiwong A, Preawnim S &Wattanapermpool J 2003 Upregulation of β1-adrenergic receptors in ovariectomized rat hearts. Life Sciences 72 1813-1824. (doi:10.1016/S0024-3205(02)02473-6)
41. Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, Schiavone A, Micheletti R, Ferrari P, Fogari R et al. 2007 Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. American Journal of Hypertension 20 663-669. (doi:10.1016/j.amjhyper.2007.01.016)
42. Villar AV, Llano M, Cobo M, Expósito V, Merino R, Martín-Durán R, Hurlé MA & Nistal JF 2009 Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. Journal of Molecular and Cellular Cardiology 46 526-535. (doi:10.1016/j.yjmcc.2008.12.024)
43. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS & Lorell BH 1999 Gender differences in molecular remodeling in pressure overload hypertrophy. Journal of the American College of Cardiology 34 264-273. (doi:10.1016/S0735-1097(99)00165-5)
44. Wu Q, Zhao Z, Sun H, Hao YL, Yan CD & Gu SL 2008 Oestrogen changed cardiomyocyte contraction and β-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion. Experimental Physiology 93 1034-1043. (doi:10.1113/expphysiol.2007.041939)
45. Zimmer G, Zimmermann R, Hess OM, Schneider J, Kübler W, Krayenbuehl HP, Hagl S & Mall G 1992 Decreased concentration of myofibrils and myofiber hypertrophy are structural determinants of impaired left ventricular function in patients with chronic heart diseases: a multiple logistic regression analysis. Journal of the American College of Cardiology 20 1135-1142. (doi:10.1016/0735-1097 (92)90369-X)